BAKER BROS. ADVISORS LP received a stock award from ACADIA PHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 6/2/2026ACC: 0001193125-26-253632
Director10% Owner
Since Sep 2018
+101.26K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
101.26K acquired
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+18.62K
Price / share
—
Trade value
—
% of position
0.5%
5/29/2026
3.66M→3.68M
Common Stock
Indirect
Shares
+18.62K
Price / share
—
Trade value
—
% of position
0.0%
5/29/2026
39.37M→39.38M
Total
Net shares
+37.24K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/29/2026 | A · Award | +18.62K | — | — | 0.5% | 3.66M | 3.68M |
| Common Stock Indirect | 5/29/2026 | A · Award | +18.62K | — | — | 0.0% | 39.37M | 39.38M |
| Total | +37.24K | $0.00 | ||||||
Derivative Transactions2
Non- Qualified Stock Option (right to buy)
Indirect
Converts to
Common Stock
32.01K shares
Shares
+32.01K
Strike price
21.66
Held after
32.01K
Exercisable
—
5/29/2026
Non- Qualified Stock Option (right to buy)
Indirect
Converts to
Common Stock
32.01K shares
Shares
+32.01K
Strike price
21.66
Held after
32.01K
Exercisable
—
5/29/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non- Qualified Stock Option (right to buy) Indirect | Common Stock32.01K shares | 5/29/2026 | A · Award | +32.01K | 21.66 | — | 32.01K |
| Non- Qualified Stock Option (right to buy) Indirect | Common Stock32.01K shares | 5/29/2026 | A · Award | +32.01K | 21.66 | — | 32.01K |
Non-Derivative Holdings (Post-Transaction)2
Common Stock
DirectShares owned102.88K
Common Stock
DirectShares owned102.88K
Total
205.75K direct205.75K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 102.88K | Direct |
| Common Stock | 102.88K | Direct |
| Total | 205.75K | 205.75K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported